3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
20
Breast Neoplasms
9
Prostatic Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Melanoma
4
Colorectal Neoplasms
4
Multiple Pulmonary Nodules
3
Head and Neck Neoplasms
3
Disease
3
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Smoking
2
Sarcopenia
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Liver Cirrhosis
2
Gastrointestinal Neoplasms
2
Anastomotic Leak
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Cessation
1
Tobacco Smoking
1
Testicular Neoplasms
1
Solitary Pulmonary Nodule
1
Interventions
Gemcitabine
4
Radiosurgery
2
Electroporation
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
surufatinib
1
Tomography, X-Ray Computed
1
S 1 (combination)
1
Pancreatectomy
1
Oxaliplatin
1
Leucovorin
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Fluorouracil
1
Endoscopy
1
Drug Therapy
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Locally Advanced Pancreatic Cancer
×
Tomography, X-Ray Computed
×
Clear all
NCT06944587
2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
400 enrolled